A spontaneous hematoma reminds columnist Jennifer Lynne of the importance of taking all symptoms and bleeding seriously with hemophilia.

Cutting-edge DNA mapping technology has identified new genetic information that can help researchers decipher more genetic ...

The UK medicines regulator has approved Pfizer’s marstacimab for patients aged 12 years or older with severe haemophilia A or B, offering a new subcutaneous treatment option.